MedPath

A phase III study of Sentinel Node Navigation Surgery for Early Gastric Cancer

Phase 3
Conditions
Clinically diagnosed T1N0 early gastric cancer
Early gastric cancer
Registration Number
JPRN-jRCTs031180432
Lead Sponsor
Kitagawa Yuko
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
All
Target Recruitment
225
Inclusion Criteria

1) Aged over 20 years old and ECOG performance status of 0 or 1
2) Clinically diagnosed T1N0M0 early gastric cancer
3) Single lesion
4) Less than 40mm in size
5) Provided written informed consent
6) Histological classification is common type of malignant epithelial tumor.

Exclusion Criteria

1) Patients pregnancy, allergic to drug such as 99m Tc tin colloid, indigo carmine and indocyanine green
2) Tumors are located in cardia or pyloric ring
3) Synchronous or metachronous (within 5 years) malignancies.
4) With prior treatment to same lesion
5) Remnant gastric cancer
6) Absolute indication for endoscopic treatments
7) Judged as irrelevant object for this study
8) Refusal of the trial entry

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath